Infection-Enhancing and -Neutralizing Activities of Mouse Monoclonal Antibodies against Dengue Type 2 and 4 Viruses Are Controlled by Complement Levels - Wikidata - thesis-toulmin - TriplyDB

Infection-Enhancing and -Neutralizing Activities of Mouse Monoclonal Antibodies against Dengue Type 2 and 4 Viruses Are Controlled by Complement Levels

Infection-Enhancing and -Neutralizing Activities of Mouse Monoclonal Antibodies against Dengue Type 2 and 4 Viruses Are Controlled by Complement Levels

http://www.wikidata.org/entity/Q27485321

about

Dengue virus pathogenesis: an integrated view Flavivirus NS1: a multifaceted enigmatic viral protein Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques The structural immunology of antibody protection against West Nile virus Alternative Complement Pathway Deregulation Is Correlated with Dengue Severity Complement and its role in protection and pathogenesis of flavivirus infections Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus The complexity of antibody-dependent enhancement of dengue virus infection The Complement System in Flavivirus Infections Issues related to recent dengue vaccine development.Evasion of the human innate immune system by dengue virus Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice.Down-regulation of complement receptors on the surface of host monocyte even as in vitro complement pathway blocking interferes in dengue infection.The NS1 glycoprotein can generate dramatic antibody-enhanced dengue viral replication in normal out-bred mice resulting in lethal multi-organ disease.Complement and viral pathogenesis Mapping the interactions of dengue virus NS1 protein with human liver proteins using a yeast two-hybrid system: identification of C1q as an interacting partner.Antibody-mediated neutralization of flaviviruses: a reductionist view.A novel reporter system for neutralizing and enhancing antibody assay against dengue virus Dengue vascular leakage is augmented by mast cell degranulation mediated by immunoglobulin Fcγ receptors.Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.Therapeutic antibodies as a treatment option for dengue fever.Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.Determination of antibody concentration as the main parameter in a dengue virus antibody-dependent enhancement assay using FcγR-expressing BHK cells.Structural mutants of dengue virus 2 transmembrane domains exhibit host-range phenotype.A mouse monoclonal antibody against dengue virus type 1 Mochizuki strain targeting envelope protein domain II and displaying strongly neutralizing but not enhancing activity.Role of complement in dengue virus infection: protection or pathogenesis?Increment of interleukin 6, tumour necrosis factor alpha, nitric oxide, C-reactive protein and apoptosis in dengue.Immune Response to Dengue and Zika.Dengue virus induces increased activity of the complement alternative pathway in infected cells.The battle between infection and host immune responses of dengue virus and its implication in dengue disease pathogenesis

P2860

Q24645380-03437693-EB4A-4002-BFEF-B8796C2A1169 Q26247192-E671C26F-D101-4846-AF75-FA5DAF4CFF5C Q27334248-4B945E43-F230-4152-A0A0-38651784F28E Q27487955-763F6A4E-4B4F-49B6-8BF1-2BA2616F9150 Q27489374-82E7C617-7CEA-45A3-806A-5A73919FC8C1 Q27490236-F5AF1677-0FD7-467C-B301-DC873A6BB1E7 Q27490423-C23CCA80-811B-4AE0-A78C-BEEBB6605C38 Q28250383-34BBE4A1-172D-46D8-B1A7-9F073DF1D0B2 Q28954726-2D442160-325C-4F08-9543-0DF5893F0486 Q30395396-88E0BB70-98EF-43AC-B847-07138F30AED6 Q33609685-13D149B0-173B-4DE5-B051-EB6EABC35BB1 Q33911897-E1AC9E3D-BB36-4AF2-86A5-0B8519E4C4D4 Q33951623-FAA956BD-2A84-4415-921E-B0298E8E34C7 Q33952146-E54034A2-C0FE-414E-A416-B4E98B5FF4D4 Q34162421-F5B922E4-925A-4FD5-AE0E-6CFA5655CACE Q34629343-90EB8788-4690-4EE3-9613-728DF61585B2 Q34999617-9CFC9B60-74C9-426F-B260-92BE7D8A349A Q35096730-AA287592-ECCB-4909-8D94-8FF0E425BBEF Q35183803-61DEAC50-9C5D-4F73-986A-F127EA4099F5 Q37123259-D7700B87-8871-47DF-BB3A-81864196C1AD Q38149195-2A14FE86-FD58-432F-9659-0845EC0A8113 Q39039111-16623280-E674-42ED-A589-001AF619E5A2 Q39117650-B391A961-0BFD-4344-9FBF-660F56E63967 Q39527825-50C1DC56-BE72-4C97-B6F1-19640EEE6FE4 Q39611340-409621EC-B289-402A-A1F3-31988DE05A08 Q40296796-A9B0A55B-D650-4C58-B6E2-5061FC848998 Q40380663-0637E136-C41A-4515-9193-B58DE6491605 Q47551925-28B76E59-CC1A-44FF-A4A0-9864F5391055 Q54216769-75E09DB6-7A7F-4661-B3C2-F9A197915113 Q56916580-DC461ADF-FDD4-437D-AABA-EC691DA064E0

P2860

Infection-Enhancing and -Neutralizing Activities of Mouse Monoclonal Antibodies against Dengue Type 2 and 4 Viruses Are Controlled by Complement Levels

http://www.wikidata.org/entity/Q27485321

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Infection-Enhancing and -Neutr ...... ontrolled by Complement Levels

@ast

Infection-Enhancing and -Neutr ...... ontrolled by Complement Levels

@en

Infection-Enhancing and -Neutr ...... ontrolled by Complement Levels

@nl

type

label

Infection-Enhancing and -Neutr ...... ontrolled by Complement Levels

@ast

Infection-Enhancing and -Neutr ...... ontrolled by Complement Levels

@en

Infection-Enhancing and -Neutr ...... ontrolled by Complement Levels

@nl

altLabel

Infection-enhancing and -neutr ...... ontrolled by complement levels

@en

prefLabel

Infection-Enhancing and -Neutr ...... ontrolled by Complement Levels

@ast

Infection-Enhancing and -Neutr ...... ontrolled by Complement Levels

@en

Infection-Enhancing and -Neutr ...... ontrolled by Complement Levels

@nl

P1433

Q27485321-5E885426-DDCC-45EE-98BE-4CFAE330BD0E

P1476

Q27485321-020632A6-276B-422A-93F2-41A75659F9CD

P2093

Q27485321-3341D625-67D9-498A-9A02-CA4F0E1F1C96

Q27485321-E170BE47-0179-40A6-BA9A-FAF685B1F2B5

Q27485321-FD2873EC-D59F-40C6-9151-34218283C1F7

P2860

Q27485321-010A88B9-2AD7-4A81-A888-2842238C5910

Q27485321-07394075-CA6A-417A-BF0E-113AE3D5F11F

Q27485321-07EF53F9-A20F-44B5-AA28-A8129D6E9474

Q27485321-0987B94D-41FE-4870-970D-E4F982384AF1

Q27485321-0CD4230B-C2B6-4FE0-A11F-825EF49C0813

Q27485321-13B85425-284C-4D07-B22A-B8BF36D1C95F

Q27485321-16912B2E-1975-4AED-B0A8-A3858C4E202B

Q27485321-19E874E1-0635-46FB-B605-E0B9D06087BF

Q27485321-1E7EF6AA-7DBB-4F66-8312-3AA0D12C6F21

Q27485321-2CE88C6E-574E-4E77-A43A-C89EF33401CE

P304

Q27485321-A3298DB0-EC96-4268-9C5D-7B74D448C4FD

P31

Q27485321-5CB46F85-0779-48B1-975C-B0811F82B075

P3181

Q27485321-98A1C97D-5FEF-4DB9-8F2C-96CB9177C6D2

P356

Q27485321-06A8C79F-F089-47B6-B214-E4B5104E79F9

P407

Q27485321-E8D0F40E-20EF-4686-8597-7FAA56AE7AC2

P433

Q27485321-1199ECDA-BB65-4C22-8B33-E390B1B994AF

P478

Q27485321-04E42A92-AFCD-42F8-B0AE-B089B29FDAAA

P577

Q27485321-6508A6A0-4EAE-454E-9E05-E6C1A3BDE59B

P698

Q27485321-7DABE97A-A20C-4696-BA8F-E05003351454

P921

Q27485321-479EABAD-7BD0-41AF-AA10-BF6BF403742B

Q27485321-A404F4E1-F4F7-4EFF-8432-6EDBD4632CE8

P932

Q27485321-536EC5F2-EFAC-4DED-8C15-7D9D70ABB5A6

P3181

P356

P1433

Journal of Virology

P1476

Infection-Enhancing and -Neutr ...... ontrolled by Complement Levels

@en

P2093

Atsushi Yamanaka

http://www.w3.org/2001/XMLSchema#string

Eiji Konishi

http://www.w3.org/2001/XMLSchema#string

Saori Kosugi

http://www.w3.org/2001/XMLSchema#string

P2860

Dengue and dengue hemorrhagic fever

Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus-transformed B-lymphocytic cell line

Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses

Continuous cultures of fused cells secreting antibody of predefined specificity

Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection

Complement receptor mediates enhanced flavivirus replication in macrophages

Understanding dengue pathogenesis: implications for vaccine design

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

P304

927-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4235189

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.00992-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18003724

http://www.w3.org/2001/XMLSchema#string

P921

P932

2224579

http://www.w3.org/2001/XMLSchema#string